BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9360053)

  • 21. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
    Reed W; Abeler VM; Tropé CG
    Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix with a focal high-grade component: is there a need for reassessment?
    Fadare O; Zheng W
    Virchows Arch; 2005 Nov; 447(5):883-7. PubMed ID: 16088403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopic decidual reaction of the uterine cervix: frequency and cytologic presentation.
    Schneider V; Barnes LA
    Acta Cytol; 1981; 25(6):616-22. PubMed ID: 6947667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytologic features of ciliated adenocarcinoma of the cervix: a case report.
    O'Connell F; Cibas ES
    Acta Cytol; 2005; 49(2):187-90. PubMed ID: 15839626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glandular lesions of the cervix on thin-layer Pap tests. Validity of cytologic criteria used in identifying significant lesions.
    Ozkan F; Ramzy I; Mody DR
    Acta Cytol; 2004; 48(3):372-9. PubMed ID: 15192953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma].
    Li H; Gou HY; Han JS; Li SM; Yang R; Qiao J
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):772-4. PubMed ID: 19173810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of cervical conization as a definitive treatment for borderline lesions of the uterine cervix].
    Matsuyama T; Tsukamoto N; Kashimura M; Iwasaka T; Saito T; Uchino H; Nakano H; Matsukuma K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2063-71. PubMed ID: 6512325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Micro-glandular hyperplasia of the uterine cervix. Histo-cytopathological evaluation, differential diagnosis and review of literature].
    Daniele E; Nuara R; Morello V; Nagar C; Tralongo V; Tomasino RM
    Pathologica; 1993; 85(1100):607-35. PubMed ID: 8170711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears.
    Novotny DB; Maygarden SJ; Johnson DE; Frable WJ
    Acta Cytol; 1992; 36(1):1-10. PubMed ID: 1546503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Villoglandular papillary adenocarcinoma of the uterine cervix.
    Collinet P; Prolongeau JF; Vaneecloo S
    Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):101-3. PubMed ID: 10471150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ; Kenny MB; Naib ZM
    Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases.
    Lu S; Shen D; Zhao Y; Kang N; Wang X
    Diagn Pathol; 2019 Jul; 14(1):72. PubMed ID: 31279344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
    Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
    Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
    Datta CK
    W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficulties in diagnosis of a minimal deviation adenocarcinoma of uterine cervix diagnosed postoperatively: brief communication and literature review.
    Stoehr A; Nann D; Staebler A; Oberlechner E; Brucker SY; Bachmann C
    Arch Gynecol Obstet; 2019 Oct; 300(4):1029-1043. PubMed ID: 31529365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid-based cytology findings of glassy cell carcinoma of the cervix. Report of a case with histologic correlation and molecular analysis.
    Ng WK; Cheung LK; Li AS
    Acta Cytol; 2004; 48(1):99-106. PubMed ID: 14969191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.
    Dietl AK; Beckmann MW; Aumann K
    Arch Gynecol Obstet; 2021 Aug; 304(2):317-327. PubMed ID: 34036437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
    Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytology, immunohistochemistry and 3-dimensional reconstruction of adenoma malignum: a case report.
    Ohta Y; Shiokawa A; Suzuki T; Kojima M
    Acta Cytol; 2005; 49(2):181-6. PubMed ID: 15839625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.